Form 4: Royalty Pharma Executive Marshall Urist Donates Partnership Interests

EVP Marshall Urist donates partnership interests exchangeable for Royalty Pharma shares to charity.

Summary

• Marshall Urist, EVP of Research & Investments at Royalty Pharma plc, filed a Form 4 indicating changes in beneficial ownership.
• On August 12, 2024, Urist donated 2,182 limited partnership interests in RPI US Partners 2019, LP to a charity.
• These partnership interests are exchangeable for Class B Interests in Royalty Pharma Holdings Limited, which in turn can be exchanged for Class A Ordinary Shares of Royalty Pharma plc.
• The donation did not involve a sale of shares or partnership interests.
• Following the transaction, Urist beneficially owns 126,412 Class A Ordinary Shares indirectly through Sandy Lamm LLC.
• Urist and family vehicles also hold 65,687 Class A Ordinary Shares and ICAI Interests exchangeable into 1,400,000 Class A Ordinary Shares.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing detailing a charitable donation. It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Positives

• The donation of partnership interests to charity is a philanthropic activity.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The charitable donation may have a minor positive impact on the company's public image.

Key Dates